Postconditioning in patients treated with primary percutaneous coronary intervention: An updated meta-analysis

Catheterization and Cardiovascular Interventions

Volumn 82, Issue 5, 2013, Pages

  Wang, Lei ^a   Wang, Jingping ^b   Xu, Huiyu ^b   Li, Bao ^b  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b Shanxi Cardiovascular Hospital   (China)

Author keywords

cardioprotection; myocardial infarction; reperfusion injury

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATINE KINASE; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN I; TROPONIN T;

ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CREATINE KINASE BLOOD LEVEL; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC POSTCONDITIONING; META ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

CARDIOPROTECTION; MYOCARDIAL INFARCTION; REPERFUSION INJURY;

BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; HUMANS; ISCHEMIC POSTCONDITIONING; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION; MYOCARDIUM; PERCUTANEOUS CORONARY INTERVENTION; RECOVERY OF FUNCTION; RISK FACTORS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84886946857     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25095     Document Type: Article

References (46)

1. Deaton C, Froelicher ES, Wu LH, Ho C, Shishani K, Jaarsma T,. The global burden of cardiovascular disease. Eur J Cardiovasc Nurs 2011; 10 Suppl 2: S5-S13.
2. Yellon DM, Hausenloy DJ,. Myocardial reperfusion injury. N Engl J Med 2007; 357: 1121-1135.
3. Gibbons RJ, Valeti US, Araoz PA, Jaffe AS,. The quantification of infarct size. J Am Coll Cardiol 2004; 44: 1533-1542.
4. Murry CE, Jennings RB, Reimer KA,. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
5. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J,. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285: H579-H588.
6. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, Aupetit JF, Bonnefoy E, Finet G, Andre-Fouet X, Ovize M,. Postconditioning the human heart. Circulation 2005; 112: 2143-2148.
7. Laskey WK,. Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: A pilot study. Catheter Cardiovasc Interv 2005; 65: 361-367.
8. Ma XJ, Zhang XH, Li CM, Luo M,. Effect of postconditioning on coronary blood flow velocity and endothelial function in patients with acute myocardial infarction. Scand Cardiovasc J 2006; 40: 327-333.
9. Yang XC, Liu Y, Wang LF, Cui L, Wang T, Ge YG, Wang HS, Li WM, Xu L, Ni ZH, Liu SH, Zhang L, Jia HM, Vinten-Johansen J, Zhao ZQ,. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention. J Invasive Cardiol 2007; 19: 424-430.
10. Laskey WK, Yoon S, Calzada N, Ricciardi MJ,. Concordant improvements in coronary flow reserve and st-segment resolution during percutaneous coronary intervention for acute myocardial infarction: A benefit of postconditioning. Catheter Cardiovasc Interv 2008; 72: 212-220.
11. Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G, Cung TT, Bonnefoy E, Angoulvant D, Aupetit JF, Finet G, Andre-Fouet X, Macia JC, Raczka F, Rossi R, Itti R, Kirkorian G, Derumeaux G, Ovize M,. Long-term benefit of postconditioning. Circulation 2008; 117: 1037-1044.
12. Hansen PR, Thibault H, Abdulla J,. Postconditioning during primary percutaneous coronary intervention: A review and meta-analysis. Int J Cardiol 2010; 144: 22-25.
13. Lonborg J, Kelbaek H, Vejlstrup N, Jorgensen E, Helqvist S, Saunamaki K, Clemmensen P, Holmvang L, Treiman M, Jensen JS, Engstrom T,. Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. Circ Cardiovasc Interv 2010; 3: 34-41.
14. Sorensson P, Saleh N, Bouvier F, Bohm F, Settergren M, Caidahl K, Tornvall P, Arheden H, Ryden L, Pernow J,. Effect of postconditioning on infarct size in patients with st elevation myocardial infarction. Heart 2010; 96: 1710-1715.
15. Freixa X, Bellera N, Ortiz-Perez JT, Jimenez M, Pare C, Bosch X, De Caralt TM, Betriu A, Masotti M,. Ischaemic postconditioning revisited: Lack of effects on infarct size following primary percutaneous coronary intervention. Eur Heart J 2012; 33: 103-112.
16. Tarantini G, Favaretto E, Marra MP, Frigo AC, Napodano M, Cacciavillani L, Giovagnoni A, Renda P, De Biasio V, Plebani M, Mion M, Zaninotto M, Isabella G, Bilato C, Iliceto S,. Postconditioning during coronary angioplasty in acute myocardial infarction: The post-ami trial. Int J Cardiol 2012, doi: 10.1016/j.ijcard.2012.03.136.
17. Higgins JPT, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
18. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21 (11): 1539-1558.
19. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327 (7414): 557-560.
20. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
21. Liu TK, Mishra AK, Ding FX,. [protective effect of ischemia postconditioning on reperfusion injury in patients with st-segment elevation acute myocardial infarction]. Zhonghua Xin Xue Guan Bing Za Zhi 2011; 39: 35-39.
22. Fan Q, Yang XC, Liu Y, Wang LF, Liu SH, Ge YG, Chen ML, Wang W, Zhang LK, Irwin MG, Xia Z,. Postconditioning attenuates myocardial injury by reducing nitro-oxidative stress in vivo in rats and in humans. Clin Sci (Lond) 2011; 120: 251-261.
23. Zhao WS, Xu L, Wang LF, Zhang L, Zhang ZY, Liu Y, Liu XL, Yang XC, Cui L,. A 60-s postconditioning protocol by percutaneous coronary intervention inhibits myocardial apoptosis in patients with acute myocardial infarction. Apoptosis 2009; 14: 1204-1211.
24. Thuny F, Lairez O, Roubille F, Mewton N, Rioufol G, Sportouch C, Sanchez I, Bergerot C, Thibault H, Cung TT, Finet G, Argaud L, Revel D, Derumeaux G, Bonnefoy-Cudraz E, Elbaz M, Piot C, Ovize M, Croisille P,. Post-conditioning reduces infarct size and edema in patients with st-segment elevation myocardial infarction. J Am Coll Cardiol 2012; 59: 2175-2181.
25. Garcia S, Henry TD, Wang YL, Chavez IJ, Pedersen WR, Lesser JR, Shroff GR, Moore L, Traverse JH,. Long-term follow-up of patients undergoing postconditioning during st-elevation myocardial infarction. J Cardiovasc Transl Res 2011; 4: 92-98.
26. Xue F, Yang X, Zhang B, Zhao C, Song J, Jiang T, Jiang W,. Postconditioning the human heart in percutaneous coronary intervention. Clin Cardiol 2010; 33: 439-444.
27. Zhao CM, Yang XJ, Yang JH, Cheng XJ, Zhao X, Zhou BY, Xu SD, Wang HF,. Effect of ischaemic postconditioning on recovery of left ventricular contractile function after acute myocardial infarction. J Int Med Res 2012; 40: 1082-1088.
28. Di Chiara A, Dall'Armellina E, Badano LP, Meduri S, Pezzutto N, Fioretti PM,. Predictive value of cardiac troponin-i compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance. J Cardiovasc Med (Hagerstown) 2010; 11: 587-592.
29. Steg PG, James SK, Atar D, Badano LP, Lundqvist CB, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, Van't Hof A, Widimsky P, Zahger D, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Astin F, Astrom-Olsson K, Budaj A, Clemmensen P, Collet JP, Fox KA, Fuat A, Gustiene O, Hamm CW, Kala P, Lancellotti P, Maggioni AP, Merkely B, Neumann FJ, Piepoli MF, Van de Werf F, Verheugt F, Wallentin L,. Esc guidelines for the management of acute myocardial infarction in patients presenting with st-segment elevation: The task force on the management of st-segment elevation acute myocardial infarction of the european society of cardiology (esc). Eur Heart J 2012; 33: 2569-2619.
30. De Silva K, Webb I, Sicard P, Lockie T, Pattinson S, Redwood S, Perera D,. Does left ventricular function continue to influence mortality following contemporary percutaneous coronary intervention? Coron Artery Dis 2012; 23: 155-161.
31. Wackers FJ, Berger HJ, Weinberg MA, Zaret BL,. Spontaneous changes in left ventricular function over the first 24 hours of acute myocardial infarction: Implications for evaluating early therapeutic interventions. Circulation 1982; 66 (4): 748-754.
32. Christian TF, Miller TD, Hodge DO, Orszulak TA, Gibbons RJ,. An estimate of the prevalence of reversible left ventricular dysfunction in patients referred for coronary artery bypass surgery. J Nucl Cardiol 1997; 4 (Pt 1): 140-146.
33. Bax JJ, Visser FC, Poldermans D, Elhendy A, Cornel JH, Boersma E, Valkema R, Van Lingen A, Fioretti PM, Visser CA,. Relationship between preoperative viability and postoperative improvement in LVEFand heart failure symptoms. J Nucl Med 2001; 42 (1): 79-86.
34. Pfeffer MA, Braunwald E,. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990; 81: 1161-1172.
35. Duncker DJ, Boontje NM, Merkus D, Versteilen A, Krysiak J, Mearini G, El-Armouche A, de Beer VJ, Lamers JM, Carrier L, Walker LA, Linke WA, Stienen GJ, van der Velden J,. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling. Circ Heart Fail 2009; 2: 233-242.
36. Beckwith C, Munger MA,. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction. Ann Pharmacother 1993; 27: 755-766.
37. Gersh BJ, Stone GW, White HD, Holmes DR Jr,. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: Is the slope of the curve the shape of the future? JAMA 2005; 293: 979-986.
38. Prasad A, Stone GW, Holmes DR, Gersh B,. Reperfusion injury, microvascular dysfunction, and cardioprotection: The "dark side" of reperfusion. Circulation 2009; 120: 2105-2112.
39. Longmore DB, Klipstein RH, Underwood SR, Firmin DN, Hounsfield GN, Watanabe M, Bland C, Fox K, Poole-Wilson PA, Rees RS,. Dimensional accuracy of magnetic resonance in studies of the heart. Lancet 1985; 1 (8442): 1360-1362.
40. Mewton N, Revel D, Bonnefoy E, Ovize M, Croisille P,. Comparison of visual scoring and quantitative planimetry methods for estimation of global infarct size on delayed enhanced cardiac mri and validation with myocardial enzymes. Eur J Radiol 2011; 78: 87-92.
41. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE,. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 2004; 43: 2253-2259.
42. Baron N, Kachenoura N, Cluzel P, Frouin F, Herment A, Grenier P, Montalescot G, Beygui F,. Comparison of various methods for quantitative evaluation of myocardial infarct volume from magnetic resonance delayed enhancement data. Int J Cardiol 2012, doi: 10.1016/j.ijcard.2012.03.056.
43. Pohost GM, Kim RJ, Kramer CM, Manning WJ,. Task force 12: Training in advanced cardiovascular imaging (cardiovascular magnetic resonance [cmr]): Endorsed by the society for cardiovascular magnetic resonance. J Am Coll Cardiol 2006; 47: 910-914.
44. Vatner SF, Baig H, Manders WT, Maroko PR,. Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase. J Clin Invest 1978; 61: 1048-1056.
45. White HD,. Pathobiology of troponin elevations: Do elevations occur with myocardial ischemia as well as necrosis? J Am Coll Cardiol. 2011; 57 (24): 2406-2408.
46. Mickenautsch S,. System research note on: Assessing publication bias. J Minim Interv Dent 2012; 5: 4-6.